51�Թ�

Stanford researchers will be presenting data at the American Society of Hematology conference next month documenting high rates of clonal hematopoiesis in lymphoma patients before they receive CAR-T treatment.

Clonal hematopoiesis, a variety of mosaicism that affects blood-forming cells and becomes more common with age, almost doubles the likelihood of developing cardiovascular disease and boosts the risk of dying from any cause by 40%.

Now a study has identified another, unexpected source of protection: clonal hematopoiesis, a blood cell imbalance best known as a risk factor for cancer and heart disease.

He wanted to study clonal hematopoiesis of indeterminate potential, or CHIP, a common but poorly understood condition that is common in older people and increases the risk for cancer and heart disease.

They named the condition with medical jargon: clonal hematopoiesis of indeterminate potential, or CHIP.